These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 32663574)
1. Histone deacetylase inhibition by MS-275 potentiates glucose-stimulated insulin secretion without affecting glucose oxidation. Zhang Y; Li M; Wang Y; Liu X; Zhou L; Zhang C; Shao L Life Sci; 2020 Sep; 257():118073. PubMed ID: 32663574 [TBL] [Abstract][Full Text] [Related]
2. Protein acetylation derepresses Serotonin Synthesis to potentiate Pancreatic Beta-Cell Function through HDAC1-PKA-Tph1 signaling. Zhang Y; Wang S; Zhang L; Zhou F; Zhu K; Zhu Q; Liu Q; Liu Y; Jiang L; Ning G; Bi Y; Zhou L; Wang X Theranostics; 2020; 10(16):7351-7368. PubMed ID: 32641996 [No Abstract] [Full Text] [Related]
3. The class I histone deacetylase inhibitor MS-275 prevents pancreatic beta cell death induced by palmitate. Plaisance V; Rolland L; Gmyr V; Annicotte JS; Kerr-Conte J; Pattou F; Abderrahmani A J Diabetes Res; 2014; 2014():195739. PubMed ID: 25610877 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of histone deacetylase 3 protects beta cells from cytokine-induced apoptosis. Chou DH; Holson EB; Wagner FF; Tang AJ; Maglathlin RL; Lewis TA; Schreiber SL; Wagner BK Chem Biol; 2012 Jun; 19(6):669-73. PubMed ID: 22726680 [TBL] [Abstract][Full Text] [Related]
5. MC1568 improves insulin secretion in islets from type 2 diabetes patients and rescues β-cell dysfunction caused by Hdac7 upregulation. Daneshpajooh M; Eliasson L; Bacos K; Ling C Acta Diabetol; 2018 Dec; 55(12):1231-1235. PubMed ID: 30088095 [TBL] [Abstract][Full Text] [Related]
6. Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children. Lundh M; Christensen DP; Damgaard Nielsen M; Richardson SJ; Dahllöf MS; Skovgaard T; Berthelsen J; Dinarello CA; Stevenazzi A; Mascagni P; Grunnet LG; Morgan NG; Mandrup-Poulsen T Diabetologia; 2012 Sep; 55(9):2421-31. PubMed ID: 22772764 [TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase 3-selective inhibitor RGFP966 ameliorates impaired glucose tolerance through β-cell protection. Lei L; Bai G; Wang X; Liu S; Xia J; Wu S; Huan Y; Shen Z Toxicol Appl Pharmacol; 2020 Nov; 406():115189. PubMed ID: 32800772 [TBL] [Abstract][Full Text] [Related]
8. Butyrate functions as a histone deacetylase inhibitor to protect pancreatic beta cells from IL-1β-induced dysfunction. Pedersen SS; Ingerslev LR; Olsen M; Prause M; Billestrup N FEBS J; 2024 Feb; 291(3):566-583. PubMed ID: 37985375 [TBL] [Abstract][Full Text] [Related]
9. Deletion of histone deacetylase 3 in adult beta cells improves glucose tolerance via increased insulin secretion. Remsberg JR; Ediger BN; Ho WY; Damle M; Li Z; Teng C; Lanzillotta C; Stoffers DA; Lazar MA Mol Metab; 2017 Jan; 6(1):30-37. PubMed ID: 28123935 [TBL] [Abstract][Full Text] [Related]
10. Sodium butyrate potentiates insulin secretion from rat islets at the expense of compromised expression of β cell identity genes. Wang S; Yuan M; Zhang L; Zhu K; Sheng C; Zhou F; Xu Z; Liu Q; Liu Y; Lu J; Wang X; Zhou L Cell Death Dis; 2022 Jan; 13(1):67. PubMed ID: 35046383 [TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion. Aune SE; Herr DJ; Mani SK; Menick DR J Mol Cell Cardiol; 2014 Jul; 72():138-45. PubMed ID: 24632412 [TBL] [Abstract][Full Text] [Related]
12. Novel culture technique involving an histone deacetylase inhibitor reduces the marginal islet mass to correct streptozotocin-induced diabetes. Shin JS; Min BH; Lim JY; Kim BK; Han HJ; Yoon KH; Kim SJ; Park CG Cell Transplant; 2011; 20(9):1321-32. PubMed ID: 21294957 [TBL] [Abstract][Full Text] [Related]
13. Glucose potentiates β-cell function by inducing Zhang Y; Deng R; Yang X; Xu W; Liu Y; Li F; Zhang J; Tang H; Ji X; Bi Y; Wang X; Zhou L; Ning G FASEB J; 2017 Dec; 31(12):5342-5355. PubMed ID: 28794173 [TBL] [Abstract][Full Text] [Related]
14. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans. Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901 [TBL] [Abstract][Full Text] [Related]
15. Histone acetylation of glucose-induced thioredoxin-interacting protein gene expression in pancreatic islets. Bompada P; Atac D; Luan C; Andersson R; Omella JD; Laakso EO; Wright J; Groop L; De Marinis Y Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):82-91. PubMed ID: 27989964 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics. Meier BC; Wagner BK Epigenomics; 2014 Apr; 6(2):209-14. PubMed ID: 24811789 [TBL] [Abstract][Full Text] [Related]
17. MS-275 inhibits aroclor 1254-induced SH-SY5Y neuronal cell toxicity by preventing the formation of the HDAC3/REST complex on the synapsin-1 promoter. Formisano L; Guida N; Laudati G; Mascolo L; Di Renzo G; Canzoniero LM J Pharmacol Exp Ther; 2015 Feb; 352(2):236-43. PubMed ID: 25467131 [TBL] [Abstract][Full Text] [Related]